Natus Medical (NTUS) 10-Q2003 Q2 Quarterly report

Filed: 14 Aug 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: arise, belief, blood, core, diagnostic, efficient, escrow, forCertain, furnishing, galactosemia, hardware, hemoglobin, hypothyroidism, II, importance, lack, mentioned, metabolic, metabolism, Moore, multiple, murphy, newly, ordinary, outsource, patient, pertaining, Phenylketonuria, PKU, president, program, reagent, release, resignation, sample, serve, spectrometry, steven, suitable, suite, tandem, thirteen, track, tracking, vice, withheld

Removed: cancel, cautioned, clinician, continuing, defer, economy, experiencing, harbor, hereof, identified, knowledge, military, pace, recent, reference, reliance, residence, safe, slowdown, sluggish, subsequent, underwriting, undue, Washington, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NTUS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO TITLE 18, UNITED STATES CODE, SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Natus Medical Incorporated (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tim C. Johnson, President and Chief Executive Officer of the Company, certify, pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ TIM C. JOHNSON
Print Name:		Tim C. Johnson
Title:		President and Chief Executive Officer Principal Executive Officer
Date:		August 13, 2003

In connection with the Quarterly Report of Natus Medical Incorporated (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven J. Murphy, Vice President, Finance of the Company, certify, pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ STEVEN J. MURPHY
Print Name:		Steven J. Murphy
Title:		Vice President, Finance Principal Financial Officer
Date:		August 13, 2003

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.